Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 683.50
-0.90 (-0.13%)
At close: Oct 13, 2025
Remus Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Net Income | 290.7 | 205.2 | 85.03 | 34.34 | 10.26 | Upgrade |
Depreciation & Amortization | 18.6 | 11 | 4.64 | 1.55 | 1.75 | Upgrade |
Other Amortization | 0.1 | 0.2 | 0.13 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -2.1 | - | - | - | - | Upgrade |
Other Operating Activities | 93.6 | 21.7 | -3.93 | -1.72 | -0.66 | Upgrade |
Change in Accounts Receivable | 72.6 | -481.2 | -19.33 | 6.89 | -19.77 | Upgrade |
Change in Inventory | -84.4 | -7.7 | 13.02 | -4.39 | -7.14 | Upgrade |
Change in Accounts Payable | -224.1 | 390.2 | -15.07 | 14.97 | 48.01 | Upgrade |
Change in Other Net Operating Assets | -95.2 | -125.9 | -11.36 | -1.26 | -4.07 | Upgrade |
Operating Cash Flow | 69.8 | 13.5 | 53.13 | 50.38 | 28.38 | Upgrade |
Operating Cash Flow Growth | 417.04% | -74.59% | 5.46% | 77.52% | 117.86% | Upgrade |
Capital Expenditures | -39.8 | -32.9 | -27.32 | -0.71 | -0.66 | Upgrade |
Sale of Property, Plant & Equipment | 3 | - | - | - | - | Upgrade |
Cash Acquisitions | - | -87.3 | - | - | - | Upgrade |
Investment in Securities | 2.7 | 32.6 | -175.48 | -30.01 | -0.67 | Upgrade |
Other Investing Activities | -42.5 | -178.3 | 3.45 | 2.44 | 0.69 | Upgrade |
Investing Cash Flow | -105.5 | -301.1 | -151.92 | -45.45 | -30.9 | Upgrade |
Short-Term Debt Issued | 89.3 | - | - | - | - | Upgrade |
Long-Term Debt Issued | 3.3 | 23.5 | 77.51 | - | - | Upgrade |
Total Debt Issued | 92.6 | 23.5 | 77.51 | - | - | Upgrade |
Short-Term Debt Repaid | - | -6.4 | - | - | - | Upgrade |
Long-Term Debt Repaid | -5.1 | -58.6 | - | -0.87 | -0.8 | Upgrade |
Total Debt Repaid | -5.1 | -65 | - | -0.87 | -0.8 | Upgrade |
Net Debt Issued (Repaid) | 87.5 | -41.5 | 77.51 | -0.87 | -0.8 | Upgrade |
Issuance of Common Stock | - | 467 | 42.5 | - | - | Upgrade |
Common Dividends Paid | -11.8 | -5.9 | - | - | - | Upgrade |
Other Financing Activities | -15 | -142.9 | -2.33 | -0.87 | -0.35 | Upgrade |
Financing Cash Flow | 60.7 | 276.7 | 117.69 | -1.74 | -1.15 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0.1 | 48 | 0 | - | 0 | Upgrade |
Net Cash Flow | 25.1 | 37.1 | 18.9 | 3.18 | -3.68 | Upgrade |
Free Cash Flow | 30 | -19.4 | 25.81 | 49.67 | 27.72 | Upgrade |
Free Cash Flow Growth | - | - | -48.03% | 79.21% | 272.81% | Upgrade |
Free Cash Flow Margin | 0.48% | -0.91% | 5.72% | 20.09% | 14.74% | Upgrade |
Free Cash Flow Per Share | 5.09 | -3.43 | 3.16 | 6.21 | 3.46 | Upgrade |
Cash Interest Paid | 14.6 | 5 | 2.33 | 0.87 | 0.35 | Upgrade |
Cash Income Tax Paid | 74.7 | 58.1 | 29.97 | 11.94 | 3.65 | Upgrade |
Levered Free Cash Flow | -108.75 | -394.05 | 7.45 | 42.87 | 24.7 | Upgrade |
Unlevered Free Cash Flow | -99.63 | -390.92 | 8.73 | 43.36 | 24.88 | Upgrade |
Change in Working Capital | -331.1 | -224.6 | -32.74 | 16.21 | 17.03 | Upgrade |
Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.